[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:new-primary-tumor":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":28,"states":29},"New Primary Tumor",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT03175224","APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors",[11],"Phase 2","RECRUITING","2026-08-26T02:18:02.701182Z","2026-05-05T02:43:28.208686Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT04094610","A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations",[19],"Phase 1\u002FPhase 2","2026-08-26T02:17:57.997171Z","2026-05-05T02:43:27.807992Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT05108298","Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials",[],"2026-08-03T03:50:03.337325Z","2026-05-05T02:43:26.987551Z",[],[30,33,36,39],{"state":31,"count":5,"slug":32},"California","california",{"state":34,"count":5,"slug":35},"Massachusetts","massachusetts",{"state":37,"count":5,"slug":38},"North Carolina","north-carolina",{"state":40,"count":5,"slug":41},"Pennsylvania","pennsylvania"]